EntryPoint Capital’s Eikon Therapeutics EIKN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$385K Buy
+47,943
New +$482K 0.11% 374

Other funds holding EIKN

EntryPoint Capital's EIKN Position: Q3 2026 in Review

EntryPoint Capital opened a new position in Eikon Therapeutics (EIKN) in Q3 2026: 47,943 shares worth $385K. The stake represents 0.11% of the portfolio and ranks #374 among its holdings.

98 funds tracked by Wall St. Rank hold EIKN as of Q3 2026.

  • EntryPoint Capital held 47,943 shares of Eikon Therapeutics worth $385K as of Q3 2026.
  • Eikon Therapeutics was a new EntryPoint Capital position in Q3 2026.
  • Eikon Therapeutics made up 0.11% of EntryPoint Capital's portfolio in Q3 2026, its #374 holding.
  • 98 funds tracked by Wall St. Rank held Eikon Therapeutics as of Q3 2026.

Based on EntryPoint Capital's 13F filing for Q3 2026, filed 13 Nov 2026.